37th Annual Scientific Meeting
18-21 March, 2025, Brisbane

With a theme of inclusivity and innovation, our Annual Scientific Meeting (ASM) brought together more than 300 researchers, health professionals and consumers from across Australia and New Zealand with the common goal of advancing cancer care through vital research.

Convened by Ms Narelle Wallace, Dr Lachlan McDowell and Mr Rob McDowall, the ASM program saw more than 65 speakers share their expertise and learnings with delegates.

We were delighted to host international guest speaker Prof Quynh-Thu Le from Stanford University, who is co-chair of the NRG Oncology Group of the NCI-sponsored US National Clinical Trial Network. TROG was accepted as a member of NRG Oncology in 2024, opening the way for participation in NRG trials, and Prof Le presented an outline of the themes, funding cycles and opportunities for collaborative research.

Other meeting highlights included an enlightening session on access and inclusivity to clinical trials for under-represented populations, and an inspiring panel discussion bringing together consumers and researchers to discuss ways to optimise collaboration in research.

The Gala Dinner, with an 80s Neon theme, provided a great platform to announce the recipients of the annual TROG Awards for Research Excellence (see below).

We extend our gratitude to ASN Events, and to the many exhibitors and sponsors whose support enabled us to host an ASM of this magnitude. Special thanks to Event partners Varian, Platinum sponsor Elekta, Gala Dinner sponsor Genesis Care and Welcome Reception sponsor Brainlab.

Plans are now underway for our 38^th ASM to be held in Melbourne, Victoria in 2026. Stay tuned for further details.

Slides Now Available

The slides from the TROG 2025 Annual Scientific Meeting are now available for viewing.

Attendees of the ASM will receive a password via email to access these presentations. Please monitor your inbox for further instructions.

FOSTERING COLLABORATION BETWEEN CONSUMERS AND RESEARCHERS

We were thrilled that more than 15 consumers from across NSW, Queensland and New Zealand could participate in the ASM as speakers, panellists and delegates.

A session on clinical trial access and inclusivity for unrepresented groups explored ways of increasing trial participation among rural and remote Australians, First Nations people and older patients, who are often excluded from trials.

Another highlight was the panel session which explored ways to improve partnerships and collaborations between researchers and consumers, facilitated by Prof Sandra Turner, radiation oncologist from Westmead Hospital. The panellists highlighted the need for diversity in consumer involvement research.